Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
46.58
-0.31 (-0.66%)
At close: Nov 20, 2024, 4:00 PM
45.00
-1.58 (-3.39%)
Pre-market: Nov 21, 2024, 5:25 AM EST
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.78 billion as of November 21, 2024. Its market cap has increased by 239.72% in one year.
Market Cap
1.78B
Enterprise Value
1.54B
1-Year Change
239.72%
Ranking
Category
Stock Price
$46.58
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.78B, an increase of 477.85%. That is a compound annual growth rate of 53.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.78B | 165.62% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tandem Diabetes Care | 1.84B |
| RxSight | 1.82B |
| Galapagos NV | 1.78B |
| Recursion Pharmaceuticals | 1.77B |
| Integra LifeSciences Holdings | 1.77B |
| AtriCure | 1.73B |
| Disc Medicine | 1.72B |
| Fortrea Holdings | 1.69B |